APTUS PHARMA LIMITED

23 Sep 2025 - 25 Sep 2025 Individual Category SME BSE

Min Investment

₹280000

Price Band

₹65-₹70

Issue Size

13.32 lakhs
Equity Shares

Lot Size

2000 (per lot)

IPO Dates
img

23 Sep 2025

Open Date

img

25 Sep 2025

Close Date

img

26 Sep 2025

Allotment Date

img

30 Sep 2025

Listing Date

Aptus Pharma IPO open date is September 23, 2025, and the closing date is September 25, 2025. This upcoming IPO is offering total issue size of 13.32 lakh equity shares entirely as a fresh issue. Aptus Pharma IPO is a book-built issue ipo with an issue price band of Rs 65 – Rs 70 per share. Aptus Pharma IPO allotment status is available on September 26, 2025. Aptus Pharma IPO lot size is 2000 shares. The minimum investment for retail investors is Rs 2,80,000. The registrar for Aptus Pharma IPO is Bigshare Services Pvt Ltd. Aptus Pharma IPO listing date is September 30, 2025.

Know Before Investing

Strengths icon

  • Diversified therapeutic portfolio covering multiple segments.
  • Outsourced manufacturing model reduces fixed asset burden.
  • Wide range of dosage forms enhancing market penetratio

Weaknesses icon

  • High inventory and receivables increase financial strain.
  • Competitive distribution and marketing environment.
  • Dependence on third-party manufacturers poses continuity risk.

About Aptus Pharma Limited

Aptus Pharma Limited, established in 2010, is headquartered in Ahmedabad and specializes in the marketing and distribution of pharmaceutical formulations across India. The company operates through an asset-light model, collaborating with WHO-GMP certified contract manufacturing partners in regions like Gujarat, Himachal Pradesh, and Uttarakhand to ensure quality standards. Its diverse product portfolio encompasses over 194 formulations across acute, chronic, wellness, and nutraceutical therapeutic areas, offering dosage forms such as tablets, capsules, syrups, ointments, injections, and sachets. Aptus Pharma boasts a robust distribution network with more than 125 direct and sub-distributors, supported by a dedicated sales team and strategically located warehouses in Ahmedabad for effective inventory management. The company has recorded strong financial growth, expanding presence in multiple states and preparing for international market entry, focusing on innovative healthcare solutions to support better patient outcomes.

Founded

2010

Managing Director

Tejash Maheshchandra Hathi

Parent Organization

-

IPO Objectives

Aptus Pharma IPO proposes to utilise the Net Proceeds from the Issue towards capital expenditure for office premises with furniture and industrial racks, meeting working capital requirements, and general corporate purposes.

Company Promoters

Tejash Maheshchandra Hathi

Chatrabhuj Vallabhbhai Butani

Kapilbhai Hasmukhbhai Chandarana

Ghanshyam Vinubhai Pansuriya

Milly Chetan Lalseta

Riddhish Natwarlal Tanna

Gaurang Rameshchandra Thakker

Kripaliben Mayank Thakker

Kunjal Piyushbhai Unadkat

Subscription Details

Investor Category Subscription (times)
Qualified Institutions 0
Non-Institutional Buyers 0
bNII (bids above ₹10L) 0
sNII (bids below ₹10L) 0
Retail Investors 0
Employees 0
Others 0
Total 0
img

How to Apply for IPO

img img

Login

Login to your Bigul Account

Select Lots & Price

Choose the number of lots and price

UPI ID

Enter your UPI ID

UPI Mandate Request

A UPI Mandate Request Triggered

Approve Mandate

Approve the UPI Mandate Request

IPO Allotment

YES Share will be credited. and the amount will be debited

Close

Let's Open Free Demat Account